American 'Deal Deficit' Gets Wider
Roche’s bid for the rest of Genentech isn’t creating anywhere near the hoopla that greeted InBev’s offer for Anheuser-Busch. It’s understandable: While many consider Genentech, of South San Francisco, the most successful... 5 months ago
DealBook - New York Times Click here to Read the Full StoryFor More News on American 'Deal Deficit' Gets Wider:
Anheuser-Busch News • San Francisco News
Digg
del.icio.us
Reddit
Stumble
Newsvine
Facebook